This inventor holds 1 USPTO granted patent and 1 published patent application and 3 EPO patents. Top assignee: Other. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,453 Years Active: 2019
Title: Frederic Bernard Louis Davi: Innovator in PCR-Based Clonality Studies
Introduction
Frederic Bernard Louis Davi is a notable inventor based in Meudon, France. He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid amplification.
Latest Patents
Davi holds a patent for "Nucleic acid amplification primers for PCR-based clonality studies." This invention is crucial for early diagnosis of lymphoproliferative disorders. The patent provides a set of nucleic acid amplification primers that include a forward primer and a reverse primer, capable of amplifying various rearrangements associated with these disorders. The primers are designed for use in PCR-based clonality studies and can aid in the detection of minimal residual disease (MRD).
Career Highlights
Throughout his career, Davi has focused on advancing techniques in molecular diagnostics. His work has been instrumental in improving the accuracy of early diagnoses in hematological conditions.
Collaborations
Davi has collaborated with Anthonie Willem Langerak, contributing to the development of innovative solutions in the field of PCR-based studies.
Conclusion
Frederic Bernard Louis Davi's contributions to nucleic acid amplification technology have paved the way for advancements in the early diagnosis of lymphoproliferative disorders. His work continues to impact the field of molecular biology significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile